Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Perfusion Culture Technique in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for Perfusion Culture Technique in Bioreactor Operations – V 2.0


Standard Operating Procedure for Perfusion Culture Technique in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/075/2025
Supersedes SOP/BS/075/2022
Page No. Page 1 of 13
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for implementing and managing perfusion culture techniques in bioreactor operations for biosimilar production, ensuring high-density cell growth and continuous product harvest under GMP compliance.

2. Scope

This SOP applies to upstream operations using perfusion culture in wave bioreactors or stirred-tank reactors for continuous production of biosimilars involving mammalian cells.

3. Responsibilities

  • Upstream Operators: Execute perfusion protocol, monitor key parameters, and document data.
  • Engineering Team: Ensure proper setup of cell retention systems and pump calibrations.
  • QA Personnel: Verify SOP adherence, review logs, and approve deviation handling.

4. Accountability

The Bioprocess Supervisor is accountable for ensuring perfusion systems are validated and operated as per approved process parameters.

5. Procedure

5.1 Preparation and Equipment Setup

  1. Ensure bioreactor is cleaned, sterilized, and pre-calibrated.
  2. Install the appropriate cell retention system (e.g., ATF, TFF, spin filter).
  3. Connect feed pumps and harvest lines with sterile connectors and tubing.
  4. Check pump flow calibration and sensor integrity (Annexure-1).

5.2 Inoculation and Initial Batch Phase

  1. Inoculate culture at 0.3–0.5 × 106 cells/mL and allow for initial batch phase (24–48 hours).
  2. Monitor cell density and metabolite levels every 8 hours.

5.3 Initiation of Perfusion

  1. Start continuous feed when cell density reaches 5 × 106 cells/mL.
  2. Begin perfusion rate at 1–2 reactor volumes per day (VVD), as per process design.
  3. Maintain steady-state cell density using controlled bleed or dilution rate.

5.4 Real-Time Monitoring

  1. Track VCD, viability, glucose, lactate, pH, and DO in real time using integrated sensors.
  2. Log all values every 4 hours in Annexure-2.
  3. Adjust feed rate or retention rate to optimize productivity.

5.5 Harvest and Termination

  1. Harvest product continuously or intermittently from the permeate stream.
  2. Terminate culture when viability drops below 70% or product concentration peaks.
  3. Disassemble system and clean per SOP/BS/098/2025.

6. Abbreviations

  • VVD: Volume Volumes per Day
  • ATF: Alternating Tangential Flow
  • TFF: Tangential Flow Filtration
  • VCD: Viable Cell Density

7. Documents

  1. Perfusion System Setup Checklist – Annexure-1
  2. Perfusion Monitoring Log – Annexure-2

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 1025 – Biopharmaceutical Process Control
  • SOP/BS/098/2025 – Bioreactor Cleaning and Sanitization

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Perfusion System Setup Checklist

Item Status Checked By Date
ATF Filter Connection OK Sunita Reddy 04/05/2025
Pump Calibration OK Sunita Reddy 04/05/2025

Annexure-2: Perfusion Monitoring Log

Date Time VCD (10^6 cells/mL) Glucose (g/L) Viability (%) Feed Rate (L/day) Remarks
04/05/2025 10:00 7.2 1.9 92 1.5 Stable

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added ATF/TFF setup steps and updated feed rate guidelines Process Optimization
See also  Biosimilars: SOP for Viral Clearance in Cell Lines - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Analytical Method Development: HPLC Content Uniformity Method – V 2.0
Next Post: Aerosol: SOP for Recording In-Process Test Results – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version